Aptose Biosciences, Inc. (APTO): Price and Financial Metrics
Today's Latest Price: $4.24 USD
Jan 28 11:13am Add APTO to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
APTO Price/Volume Stats
Aptose Biosciences, Inc. (APTO) Company Bio
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. The company was founded in 1986 and is based in Mississauga, Canada.
APTO Latest News Stream
All News Types
Loading, please wait...
Latest APTO News From Around the Web
Below are the latest news stories about Aptose Biosciences Inc that investors may wish to consider to help them evaluate APTO as an investment opportunity.
Aerpio (ARPO) unveils strategic alternatives after it announced top-line results from a phase II study of razuprotafib in glaucoma patients in December.
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious towards the current bull run since March and hedging or reducing many of their long positions. Some fund managers are betting on Dow hitting […]
Novartis (NVS) gets positive review from the FDA Advisory Committee to support the use of Entresto in the treatment of patients with heart failure with preserved ejection fraction.
Athenex (ATNX) wins the FDA nod for Klisyri as a topical treatment of actinic keratosis on the face or scalp. The drug will be launched in the first quarter of 2021 in the United States.
The FDA approves Roche's (RHHBY) Ocrevus for two-hour infusion time, dosed twice-yearly to patients with relapsing or primary progressive MS.
Read More 'APTO' Stories Here
APTO Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7485 seconds.